Warning: Semaglutide will not be prescribed to anyone with the following conditions: BMI under 27, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2, or a family history of medullary thyroid carcinoma.
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation
[3] [5] Any information about wearing periods for GLP-1 patches relates to investigational products that may be in development or testing phases
The idea: escalate to 9-12mg for initial weight loss, then step down to 4mg for long-term maintenance